PM359

· Prime Medicine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PM359, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) [Phase 1, Phase 2]

See pricing